Search

Search Constraints

You searched for: Author/Creator Bradding, Peter

Search Results

2. A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Issue 12 (4th October 2020)

3. Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma. Issue 10 (25th May 2022)

4. Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling. Issue 5 (2nd May 2017)

6. Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study. Issue 8 (2nd April 2019)

7. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Issue 1 (January 2021)

8. Endothelial protein C receptor is overexpressed in colorectal cancer as a result of amplification and hypomethylation of chromosome 20q. (14th July 2017)